Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec 1;46(6):1764-1772.
doi: 10.1093/ije/dyx088.

Focus on an unusual rise in pancreatic cancer incidence in France

Affiliations

Focus on an unusual rise in pancreatic cancer incidence in France

Anne-Marie Bouvier et al. Int J Epidemiol. .

Abstract

Background: Pancreatic cancer is one of the most lethal. Most countries have exhibited a stable or decreasing incidence over time. The aim of this study was to provide updated French temporal trends in pancreatic cancer incidence and mortality over the past three decades.

Methods: Incidence was estimated using the French National Network of Cancer Registries (FRANCIM) and mortality using the French Mortality Statistics Office. World age-standardized incidence and mortality were modelled by age-period-cohort models. The net cumulative risk of developing pancreatic cancer by birth cohort was calculated, as were annual percentage changes (APCs) in incidence and mortality.

Results: Between 1982 and 2012, age-standardized incidence increased from 4.8 in 1980 to 9.6 per 100 000 in men and from 2.3 to 6.8 in women. The mean APC was 2.3% (2.1-2.6) and 3.6% (3.3-3.9), respectively. The cumulative risk of developing pancreatic cancer before age 75 rose from 0.62% for males born around 1920 to 1.17% for those born around 1950. It was respectively 0.31% and 0.86% for women. Mortality did not vary in men (8.1 per 100 000). It slightly increased in women from 4.0 in 1982 to 5.4 in 2012.

Conclusion: Pancreatic cancer incidence and mortality exhibited diverging trends. Incidence increased over the last 30 years in France whereas mortality did not vary in men and moderately increased in women. Incidence remained lower than mortality up to 2002. One cannot exclude the possibility that a similar trend may appear in other countries. Etiological studies are required to further explain this increase.

Keywords: cancer registry; epidemiology; incidence; mortality; pancreatic cancer.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Time trends in age-standardized (world) incidence and mortality from pancreatic cancer in France (registry areas) from 1982 to 2012: modelled vs observed rates in men (a) and women (b).
Figure 2.
Figure 2.
Incidence and mortality rates (per 100 000 PY) of pancreatic cancer according to birth cohorts for selected age, in men (a) and women (b).

Comment in

References

    1. Ferlay J, Soerjomataram I, Ervik M. et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon: International Agency for Research on Cancer, 2013.
    1. Howlader N, Noone AM, Krapcho M. et al. SEER Cancer Statistics Review, 1975–2012, National Cancer Institute. SEER Cancer Statistics Review, 1975–2013, National Cancer Institute. Bethesda, MD, 2016. http://seer.cancer.gov/csr/1975_2013/ (28 April 2017, date last accessed).
    1. Lepage C, Capocaccia R, Hackl M. et al. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999–2007: results of EUROCARE-5. Eur J Cancer 2015;51:2169–78. - PubMed
    1. Coleman M, Esteve J, Damiecki P. et al. Trends in Cancer Incidence and Mortality, IARC ed. Lyon: Scientific Publication, 1993. - PubMed
    1. Bouvier AM, David M, Jooste V. et al. Rising incidence of pancreatic cancer in France. Pancreas 2010;39:1243–6. - PubMed